(Reuters) -Shares of Applied Nutrition rose 12% on Tuesday after the British supplements maker forecast revenue for its fiscal year 2025 and 2026 to exceed market expectations amid global expansion.
Applied Nutrition's Shares Climb 12% on Positive Revenue Forecast
Applied Nutrition's Strong Revenue Outlook
(Reuters) -Shares of Applied Nutrition rose 12% on Tuesday after the British supplements maker forecast revenue for its fiscal year 2025 and 2026 to exceed market expectations amid global expansion.
Company Overview and Market Position
The company, which went public in October 2024 in one of the largest London IPOs of that year, said it expects annual revenue to rise 24% to 107 million pounds ($144.61 million), above analysts' consensus of 100 million pounds, according to a company-compiled poll.
Revenue Projections and Analyst Expectations
Applied Nutrition, which sells products in over 85 countries, has been expanding listings and shelf space in key retailers such as Asda and Tesco in the UK, its biggest market.
Impact of Retail Partnerships
Revenue for the financial year ending July 2026 is also expected to surpass market expectation of 112.4 million pounds.
Shares of the company are on track for its best day since the IPO.
($1 = 0.7399 pounds)
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Harikrishnan Nair)
